Viewing nowCombinationAmlobaltan Tablet 10/160 Milligrams
Amlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Sinphong Pharmaceutical Co., Ltd.

MFDS item code 201308341 · Approved 2013.07.22 · Insurance code 648507010
Treatment of essential hypertension inadequately controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension who do not achieve sufficient control with monotherapy of amlodipine or valsartan. It helps to manage blood pressure stably and reduce the risk of cardiovascular complications.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
Pediatric patients under 18 years of age: The safety and efficacy have not been established; therefore, use of this medicine is not recommended.
This medication can cause severe harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be given to individuals allergic to its components or to pregnant women, nursing mothers, patients with severe renal or hepatic impairment, or patients with certain heart conditions. Patients with depleted sodium or fluid levels may experience hypotension, so their condition should be thoroughly checked before use, and appropriate action must be taken if hypotension symptoms appear during treatment. Patients with high potassium levels or those taking potassium supplements should be careful to monitor potassium levels frequently to prevent abnormalities. Patients with kidney issues or those who have received a kidney transplant should closely monitor renal function while taking this medication, and should discontinue it immediately if signs of angioedema occur. Patients with heart failure or those recovering from myocardial infarction should periodically check their renal function and blood pressure changes while taking this medication and consult a healthcare professional if symptoms worsen. Be cautious of dizziness or fatigue when driving or operating machinery. This medication may interact with other antihypertensives, potassium-sparing diuretics, and certain anti-inflammatory drugs, so it is important to consult a doctor or pharmacist if other medications are being taken. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers are also advised to avoid it. Safety and efficacy in children have not been sufficiently established, so use in this population is not recommended. Overdosage may result in severe hypotension or heart-related problems, so it is essential to adhere to the prescribed dosage and to notify healthcare personnel immediately if abnormal symptoms arise. It is important to consult a healthcare professional quickly if any abnormal symptoms or discomfort occur during treatment with this medication.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, sensory abnormalities, lightheadedness, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, tonsillitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory impairment, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurogenic irritability, sensory impairment, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container, protected from air and moisture. It is advisable to keep it at room temperature between 1 to 30 degrees Celsius.
Bright yellow, egg-shaped film-coated tablet
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.87mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Sinphong Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.